CWM Advisors LLC Boosts Stock Holdings in Agilent Technologies Inc (NYSE:A)

CWM Advisors LLC lifted its position in shares of Agilent Technologies Inc (NYSE:A) by 12.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,288 shares of the medical research company’s stock after acquiring an additional 1,807 shares during the period. CWM Advisors LLC’s holdings in Agilent Technologies were worth $1,216,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently modified their holdings of A. Harvey Investment Co. LLC lifted its stake in Agilent Technologies by 35.7% in the 2nd quarter. Harvey Investment Co. LLC now owns 147,500 shares of the medical research company’s stock valued at $11,014,000 after purchasing an additional 38,805 shares during the last quarter. IFM Investors Pty Ltd raised its stake in shares of Agilent Technologies by 13.3% during the second quarter. IFM Investors Pty Ltd now owns 22,515 shares of the medical research company’s stock valued at $1,681,000 after acquiring an additional 2,649 shares during the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of Agilent Technologies by 10.0% during the second quarter. Oregon Public Employees Retirement Fund now owns 73,312 shares of the medical research company’s stock valued at $5,474,000 after acquiring an additional 6,637 shares during the last quarter. Fruth Investment Management raised its stake in shares of Agilent Technologies by 0.8% during the second quarter. Fruth Investment Management now owns 44,539 shares of the medical research company’s stock valued at $3,325,000 after acquiring an additional 338 shares during the last quarter. Finally, Xact Kapitalforvaltning AB raised its stake in shares of Agilent Technologies by 4.0% during the second quarter. Xact Kapitalforvaltning AB now owns 66,040 shares of the medical research company’s stock valued at $4,931,000 after acquiring an additional 2,519 shares during the last quarter.

Several research firms have recently issued reports on A. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 12th. Deutsche Bank dropped their price target on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. Needham & Company LLC raised their price target on shares of Agilent Technologies to $92.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Piper Jaffray Companies increased their price objective on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. Finally, Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research report on Tuesday, July 16th. Six equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $84.77.

NYSE:A opened at $69.55 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.72 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $21.90 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 1.96 and a beta of 1.41. The firm has a fifty day simple moving average of $70.20 and a two-hundred day simple moving average of $74.46. Agilent Technologies Inc has a 12 month low of $61.01 and a 12 month high of $82.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 14th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.72 by $0.04. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.24 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The business’s revenue was up 5.6% on a year-over-year basis. During the same period last year, the company earned $0.67 earnings per share. Equities analysts predict that Agilent Technologies Inc will post 3.08 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: Technical Analysis of Stocks and What It Means

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.